GLOBAL X FDS - GENOMIC BIOTECH (GNOM)

Historical Portfolio Holders from Q1 2019 to Q3 2024

All holders as of September 30, 2024
Q3 2024
Type / Class
Equity / GENOMIC BIOTECH
Shares, excl. options Q3 2024
3.11M
Holdings value Q3 2024
$35M
Value change Q3 2024
+$3.01M
Grand Portfolio weight change Q3 2024
+0%
Number of holders
60
Number of buys Q3 2024
22
Number of sells Q3 2024
-26
Average buys Q3 2024 %
+0%
Average sells Q3 2024 %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q3 3.11M $35M +$3.01M $11.25 60
2024 Q2 2.86M $29.8M -$1.69M $10.44 62
2024 Q1 2.71M $31M -$4.83M $11.38 58
2023 Q4 3.13M $36.2M -$104M $11.56 59
2023 Q3 12.2M $124M +$16.6M $10.17 62
2023 Q2 10.5M $127M -$8.43M $12.12 61
2023 Q1 11.2M $138M +$7.5M $12.32 62
2022 Q4 10.6M $309M +$630K $12.65 64
2022 Q3 10.7M $134M +$20M $12.55 53
2022 Q2 9.03M $110M +$55.6M $12.22 53
2022 Q1 4.47M $67.2M -$15.9M $15.03 58
2021 Q4 5.4M $107M -$2.23M $19.85 58
2021 Q3 5.47M $121M +$42.1M $22.15 53
2021 Q2 3.56M $88.2M +$4.13M $24.89 44
2021 Q1 3.4M $76.4M +$18.4M $22.48 37
2020 Q4 2.53M $59.9M +$9.76M $23.67 26
2020 Q3 2.12M $38M +$9.09M $17.98 18
2020 Q2 1.61M $28.3M +$13.8M $17.56 8
2020 Q1 826K $10.5M -$346K $12.46 7
2019 Q4 833K $13M +$744K $15.61 9
2019 Q3 785K $9.81M +$9.42M $12.46 5
2019 Q2 26.8K $415K +$391K $15.38 3
2019 Q1 973 $24K $0 $24.67 1